サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1643990

小児用ワクチンの世界市場：2033年までの機会と戦略

Pediatric Vaccine Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 286 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.66円
小児用ワクチンの世界市場：2033年までの機会と戦略
出版日: 2025年01月27日
発行: The Business Research Company
ページ情報: 英文 286 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の小児用ワクチン市場は、2018年に297億5,009万米ドルとなり、2023年まで6.00%以上のCAGR（複合年間成長率）で成長しました。

開発途上地域における出生率の増加

開発途上地域における出生率の増加が、この実績期間における小児用ワクチン市場の成長を牽引しました。新興地域における出生率とは、工業化、所得水準、ヘルスケアへのアクセスが低い国々における人口1,000人当たりの出生数を指します。発展途上地域における出生率の増加は、家族計画へのアクセス制限、大家族を好む文化的規範、教育水準の低さ、経済的課題、乳幼児生存率の上昇につながる不十分なヘルスケアサービスなどの要因に起因しています。

目次

第1章 エグゼクティブサマリー

  • 小児用ワクチン-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 小児用ワクチン市場定義とセグメンテーション
  • 市場セグメンテーション：ワクチンタイプ別
    • 一価ワクチン
    • 多価ワクチン
  • 市場セグメンテーション：技術別
    • 生弱毒化ワクチン
    • 不活化ワクチン
    • トキソイドワクチン
    • 結合ワクチン
    • その他のテクノロジー
  • 市場セグメンテーション：用途別
    • 感染症
    • アレルギー
    • がん
    • 肺炎球菌感染症
    • インフルエンザ
    • 麻疹、風疹、おたふく風邪（MMR）
    • その他の用途

第7章 主要な市場動向

  • 公衆衛生の向上を目指した新しい小児用ワクチンの開発
  • 肺炎球菌感染症から子供を守る結合ワクチンの進歩
  • 革新的な不活化ポリオウイルスワクチンがポリオ撲滅プログラムを支援

第8章 小児用ワクチン市場-マクロ経済シナリオ

  • COVID-19の影響：小児用ワクチン市場
  • ウクライナ戦争の影響：小児用ワクチン市場
  • 高インフレの影響：小児用ワクチン市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018年～2023年
    • 市場促進要因、2018年～2023年
    • 市場抑制要因、2018年～2023年
  • 市場成長予測、2023年～2028年、2033年
    • 市場促進要因、2023年～2028年
    • 市場抑制要因、2023年～2028年

第10章 世界の小児用ワクチン市場：セグメンテーション

  • 世界の小児用ワクチン市場ワクチンタイプ別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の小児用ワクチン市場：技術別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の小児用ワクチン市場：用途別、実績と予測、2018年～2023年、2028年、2033年

第11章 小児用ワクチン市場：地域・国別分析

  • 世界の小児用ワクチン市場：地域別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の小児用ワクチン市場：国別、実績と予測、2018年～2023年、2028年、2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Pfizer Inc
  • Seqirus（CSL Limited）
  • GlaxoSmithKline plc

第20章 その他の大手企業と革新的企業

  • Johnson & Johnson
  • Daiichi Sankyo Co. Ltd
  • Novavax, Inc
  • AstraZeneca Plc
  • Novartis AG
  • BioNTech
  • Zydus Lifesciences Limited
  • Walvax Biotechnology Co. Ltd
  • Indian Immunologicals Limited
  • Sinovac Biotech Ltd
  • Serum Institute of India
  • Ezequiel Dias Foundation（FUNED）
  • Bharat Biotech International Limited
  • Panacea Biotec
  • MCM Vaccine B.V

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • SK bioscienceがIDT Biologikaを買収
  • GlaxoSmithKline Public Limited CompanyがAffinivax Incを買収

第24章 機会と戦略

  • 世界の小児用ワクチン市場、2028年：最も新たな機会を提供する国
  • 世界の小児用ワクチン市場、2028年：最も新たな機会を提供するセグメント
  • 世界の小児用ワクチン市場、2028年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 小児用ワクチン市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1453

Pediatric vaccines are immunizations specifically designed to protect children from various infectious diseases. These vaccines are administered during infancy and childhood from birth till 18 years. Moreover, these vaccines stimulate the immune system to recognize and combat pathogens, thereby preventing illnesses such as measles, mumps, rubella, polio and hepatitis.

The pediatric vaccine market consists of sales, by entities (organizations, sole traders and partnerships), of pediatric vaccine that are used by healthcare providers, including pediatricians, family physicians and public health clinics, who administer these vaccines according to established immunization schedules. Parents and guardians are also key stakeholders, ensuring their children receive timely vaccinations. Pediatric vaccines are typically administered during routine healthcare visits, starting from birth and continuing through adolescence, following schedules recommended by health authorities.

The global pediatric vaccine market was valued at $29,750.09 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

Increasing Birth Rates in Developing Regions

Increasing birth rates in developing regions drove the growth of the pediatric vaccine market during this historic period. Birth rates in developing regions refer to the number of live births per 1,000 people in countries with lower industrialization, income levels and access to healthcare. Increasing birth rates in developing regions can be attributed to factors such as limited access to family planning, cultural norms that favor larger families, lower levels of education, economic challenges and inadequate healthcare services that lead to higher infant survival rates.

Pediatric vaccines support increasing birth rates in developing regions by enhancing child survival, lowering infant mortality and improving overall health, which encourages families to have more children due to greater confidence in their children's well-being. For instance, in March 2024, according to Eurostat, a Belgium-based governing body, the number of live births in the EU increased slightly from 4.07 million in 2020 to 4.09 million in 2021. Therefore, increasing birth rates in developing regions contributed to the growth of the pediatric vaccine market.

Developing New Pediatric Vaccines For Better Public Health Outcomes

Major companies operating in the pediatric vaccine market are focusing on developing new vaccines for better public health outcomes. These vaccines, often included in national schedules, boost awareness and adoption among parents and healthcare providers. For example, in September 2024, Immunologicals Limited, an India-based pharmaceutical company specializing in vaccines and immunological products, launched Havisure Hepatitis A vaccine. Havisure Hepatitis A is a vaccine developed for pediatric use, offered in a 0.5 ml dosage to protect children against Hepatitis A, a highly contagious liver infection. This vaccine represents a significant step in India's commitment to providing affordable and effective immunization, particularly for vulnerable groups such as children. Its launch supports India's "Make in India" initiative, enhancing the country's vaccine self-sufficiency and contributing to better public health outcomes.

The global pediatric vaccine market is highly concentrated, with large players in the market. The top ten competitors in the market made up to 60.85% of the total market in 2023.

Pediatric Vaccine Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pediatric vaccine market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for pediatric vaccine? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pediatric vaccine market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pediatric vaccine market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by vaccine type, by technology and by application.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pediatric vaccine market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by vaccine type, by technology and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for pediatric vaccine providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Vaccine Type: Monovalent Vaccines; Multivalent Vaccines
  • 2) By Technology: Live Attenuated Vaccines; Inactivated Vaccines; Toxoid Vaccines; Conjugate Vaccines; Other Technologies
  • 3) By Application: Infectious Disease; Allergy; Cancer; Pneumococcal Disease; Influenza; Measles, Mumps And Rubella; Other Applications
  • Companies Mentioned: Merck & Co.Inc.; SANOFI S.A.; Pfizer, Inc.; Seqirus (CSL Limited); GlaxoSmithKline plc
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pediatric vaccine indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Pediatric Vaccine - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Pediatric Vaccine Market Definition And Segmentations
  • 6.4 Market Segmentation By Vaccine Type
    • 6.4.1 Monovalent Vaccines
    • 6.4.2 Multivalent Vaccines
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Live Attenuated Vaccines
    • 6.5.2 Inactivated Vaccines
    • 6.5.3 Toxoid Vaccines
    • 6.5.4 Conjugate Vaccines
    • 6.5.5 Other Technologies
  • 6.6 Market Segmentation By Application
    • 6.6.1 Infectious Disease
    • 6.6.2 Allergy
    • 6.6.3 Cancer
    • 6.6.4 Pneumococcal Disease
    • 6.6.5 Influenza
    • 6.6.6 Measles, Mumps And Rubella (MMR)
    • 6.6.7 Other Applications

7 Major Market Trends

  • 7.1 Developing New Pediatric Vaccines For Better Public Health Outcomes
  • 7.2 Advancements In Conjugate Vaccines For Protecting Children Against Pneumococcal Disease
  • 7.3 Innovative Inactivated Poliovirus Vaccine Aids Polio Eradication Programs

8 Pediatric Vaccine Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Pediatric Vaccine Market
  • 8.2 Impact Of The War In Ukraine On The Pediatric Vaccine Market
  • 8.3 Impact Of High Inflation On The Pediatric Vaccine Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Pediatric Vaccine Market Segmentation

  • 10.1 Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Pediatric Vaccine Market, Regional and Country Analysis

  • 11.1 Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Pediatric Vaccine Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.1 China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.2 Japan Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.3 South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate tax structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 UK Market
  • 13.7 UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.1 Germany Market
  • 13.11 Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.2 Italy Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major companies
  • 14.3 Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Pediatric Vaccine Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.1 Russia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Pediatric Vaccine Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.1 USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Pediatric Vaccine Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.1 Brazil Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

  • 19.1 Company Profiles
  • 19.2 Merck & Co., Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Sanofi S.A.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Pfizer Inc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Seqirus (CSL Limited)
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 GlaxoSmithKline plc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Johnson & Johnson
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Daiichi Sankyo Co. Ltd
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 Novavax, Inc
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 AstraZeneca Plc
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Novartis AG
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 BioNTech
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Zydus Lifesciences Limited
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Walvax Biotechnology Co. Ltd
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Indian Immunologicals Limited
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.1 Sinovac Biotech Ltd
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Serum Institute of India
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Ezequiel Dias Foundation (FUNED)
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Bharat Biotech International Limited
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Panacea Biotec
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 MCM Vaccine B.V
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 SK bioscience Acquired IDT Biologika
  • 23.2 GlaxoSmithKline Public Limited Company Acquired Affinivax Inc

24 Opportunities And Strategies

  • 24.1 Global Pediatric Vaccine Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Pediatric Vaccine Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Pediatric Vaccine Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Pediatric Vaccine Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer